Medindia
Medindia LOGIN REGISTER
Advertisement

New Study Shows Consumers Embracing Health Wearables, DNA Tests, and Online Health Portals - but Physicians Unsure How to Incorporate Them Into Patient Care

Wednesday, September 26, 2018 Genetics & Stem Cells News
Advertisement
Consumers adopting new health care technologies like Fitbits and DNA testing are way ahead of their primary care physicians, according to a new Zeldis Research and Schlesinger Group study, "The Consumerization of Health Care".
Advertisement

EWING, N.J., Sept. 26, 2018 /PRNewswire-PRWeb/ -- Consumers adopting new health care technologies like Fitbits and DNA testing are way ahead of their primary care physicians, according to a new Zeldis Research and Schlesinger Group study, "The Consumerization of Health Care".
Advertisement

For this study, patients and doctors were asked about consumer adoption of fitness and health wearables, remote monitoring, patient portals and other convenience products to maintain wellness. The study seeks to better understand how both consumers and physicians view the practice of consumers taking a greater role in managing their own health care.

The Findings

The study found that consumers are excited about using wearables and apps to enhance their health information, but perceive their physicians – especially older practitioners – as naïve about technologies and, therefore, rarely share the results with their doctors. The majority of primary care physicians participating in the study said they welcome patient use of wearables and health apps, but have limited experience with them and only occasionally ask patients about them.

Consumers are also eager to share consumer DNA test results with their caregivers as a way to adjust their lifestyles to offset discovered risks. But while physicians expect growing patient interest in wearables, health apps and consumer DNA tests, they are unsure how to incorporate the information into their patient care.

"Consumer health tech is disconnected from the health care system. Consumers use it and providers are happy they do. But consumers rarely share it and providers rarely ask about it." said Jeff Mann, Zeldis Senior Research Director.

The interviews were conducted in July of 2018. A second, large-scale quantitative phase of the study will be conducted in Fall, 2018 with results expected by December 2018.

About Zeldis Research:

Zeldis Research Associates has been conducting customized market research using a variety of traditional and innovative methods since 1991. The company is unique in its ability to offer highly actionable results through its boutique size, deep and broad knowledge in the markets it serves, and its blend of qualitative and quantitative research approaches.

 

SOURCE Zeldis Research Associates, Inc.

Sponsored Post and Backlink Submission


Latest Press Release on Genetics & Stem Cells News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close